Stay updated on GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.

Latest updates to the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedTerminated with no longer recruiting and results posted. The updates include dosing cohort details and the actual enrollment numbers, reflecting the trial's closure.SummaryDifference10%

- Check13 days agoChange DetectedNew navigation/help sections were added to the study record page, including 'Check who can join', 'Find Contact Information', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. A heading label was updated from 'Intervention / Treatment' to 'Intervention/Treatment', and the site release note was updated to 'Revision: v3.6.0' (replacing the previous 'Revision: v3.5.5').SummaryDifference0.6%

- Check21 days agoChange DetectedThe page revision indicator was updated from v3.5.4 to v3.5.5, signaling a new revision of the study page. This reflects an internal version update and does not imply substantive changes to the study data.SummaryDifference0.2%

- Check35 days agoChange DetectedNo additions or deletions were reported in the provided change data. The page content remains unchanged according to the given information.SummaryDifference0.1%

- Check42 days agoChange DetectedNew revision label v3.5.4 replaces the previous v3.5.3. This indicates an updated software build of the page rather than a change to substantive study information.SummaryDifference0.1%

- Check56 days agoChange DetectedThe revision tag on the study page was updated from v3.5.2 to v3.5.3, indicating a minor administrative update to the record. This update does not alter the study details or participant information.SummaryDifference0.1%

Stay in the know with updates to GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.